Figure 11.
Antitumor activity of ARD-2128 in the VCaP xenograft tumor model in SCID mice. Enzalutamide was included as a control. Each compound was dosed via oral gavage daily for a total of 21 days.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.